global glp-1 market size 2025 Agonists Weight Loss Drugs Report, 2025-2030 GLP-1 Receptor Agonist Market Size

A large Swedish study published in 2018 analysed over 100,000 patients and found no association between GLP-1 receptor agonist use and pancreatic cancer

On April 22, 2025 , DSM-Firmenich entered into strategic collaborations with biotechnology firms to develop advanced delivery systems such as liposomal and nano-formulated glutathione, improving stability and bioavailability for dietary supplements and pharmaceutical applications

In the human body, a lack of glutathione leads to many diseases, such as Parkinson's disease, tyrosinemia type I, alcohol poisoning and others

58 KalariaR

Impaired methylation can lead to elevated homocysteine concentrations and altered DNA methylation, both of which have been associated with an increased risk of cardiovascular disease, neurological disorders, and other chronic health conditions

Yet theres limited guidance on how to transition off medication while maintaining weight loss successfully